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The gene organisation of the human ,62 integrin subunit (CD18) 
Jonathan B. Weitzman. Charmian E. Wells, Ann H. Wright, Paula A. Clark and S.K. Alex Law 
We have studied the gcnc of the human 82 integrin subunit (CD18) and found it to be organised into 16 exons spanning a region of about 40 kb. 
All exoniintron boundaries conform 10 the G’l‘iAG splicing consensus. The exons coding for the cysleine-rich region, which has been postulated 
to consist of 3 or 4 repeating elements. arc not organiscd correspondingly. Transcription of the gene initiates from multiple sites which may be 
due to the abscncc of an upstream TATA box. The polyadcnylation site is also heterogeneous. Five different sites were identified over a stretch 
of IO bases. 
Integrin: Gcnc structure; Exoniintron boundary 
1. INTRODUCTION 
The integrins are cell surface antigens that mediate a 
wide range of cell adhesion activities (for reviews see 
[ 1,2]. They are heterodimeric glycoproteins composed 
of an CL and a p subunit. The cr subunits characterised 
to date arc similar in their primary structures, as are the 
p subunits. 
/?2 gene resulting in the failure to express any of the 3 
leukocyte integrins [I I]. Heterogeneity of the defect was 
demonstrated at the phenotypic level [12]. At the molec- 
ular level, 5 different mutations have been reported; 
they are all single base changes resulting in either amino 
acid substitutions [I 3,141 or exon deletion due to 
aberrant splicing [15]. In this paper we report the ge- 
nomic organisation of the /?2 integrin (CD18) gene. 
The 3 members of the leukocyte integrin subfamily 
are expressed exclusively on leukocytes and participate 
in adhesion activities, including the cytolysis of target 
cells, cross-interaction and cross-stimulation between 
lymphocytes, phagocytosis of complement-coated 
targets, and the regulation of leukocyte traffic between 
the blood stream and tissues [3,4]. The three a subunits, 
aL (CDlla), aM (CDllb) and aX (CDllc), each as- 
sociate with the common 82 subunit (CDl8) to form, 
respectively, the antigens LFA-1, Mac-l and pl50,95 
PI. 
2. MATERIALS AND METHODS 
The gene of the p2 subunit (CDl8) has been located 
to chromosome 21 [6] band q22.3 [7,8], and, using radia- 
tion hybrid mapping and pulsed-field gel electrophore- 
sis. its location has been refined to about 2000 kb from 
the q telomcre [9]. The p2 gene is extremely poly- 
morphic; at least 10 different haplotypes over 3 loci in 
20 healthy, unrelated individuals have been identified 
by RFLP analysis [lo]. Patients suffering from leu- 
kocyte adhesion deficiency (LAD) have defects in their 
Genomic DNA was prepared from peripheral blood leukocytes 
using the method of Bell et al. [16]. Bglfl-digested genomic DNA was 
fractionated by ultracentrifugation through a sucrose density 
gradient. 3OOpg of BgIII-digested genomic DNA, in 400 ,uI of IO mM 
Tris, 0.1 mM EDTA, pH 8.0, was layered onto 4 sucrose density 
gradients made with 2 ml of each of 45,40,35,30,25 and 20% sucrose 
in 25 mM Tris, I mM EDTA, 0.2% SDS, pH 8.0, in 14 ml Ultra-Clear 
centrifuge tubes (Beckman). Ultracentrifugation was carried out with 
an SW40Ti rotor in a Beckman L-8 ultracentrifuge at 2O”C, 28 000 
rpm, for 20 h. Eighteen fractions were collected from each of the 4 
gradients and the corresponding fractions were pooled. 
Oligonucleotides were synthesised in an automated synthesiser 
(Applied Biosystems, Model 38lA). CD18 specific oligonucleotides 
are marked in Fig. I A. A DNA Thermal Cycler (Perkin Elmer Cetus) 
was used for PCR: reactions wcrc performed in a standard buffer 
containing 1 .S mM MgCI,. Trrq DNA polymerase was obtained from 
Perkin Elmer Cetus or Promega. Primers were used at I PM except 
in RACE-PCR. Annealing temperature ranged from 50 to 60°C 
depending on the primer sequences. 
Ahbrevictrions: PCR, polymerase chain reaction; RACE, rapid ampli- 
fication of cDNA ends; PAGE, polyacrylamide gel electrophoresis: 
PM/\, phorbol myristate acetate; RFLP. restriction fragment length 
polymorphism. 
Correspondence rrddress: S.K.A. Law, The MRC Immunochemistry 
Unit, Department of Biochemistry, University of Oxford, South Parks 
Road, Oxford OX1 3QU. UK. Fax: (44) (865) 275 729. 
A probe for RNase protection analysis was synthesised using the 
hybrid clone pRS’G (see Fig. 3A). The clone was lineariscd with XhoI 
and a continuously labelled RNA probe was made using SZP-aCTP 
and T3 RNA polymerase with other reagents from the Riboprobe 
system (Promega). About 2 x lo’ cpm of the probe was added to 150 
pg of RNA from PMA-stimulated U937 cells or tRNA in 40 mM 
PIPES, 400 mM NaCI, I mM EDTA, pH 6.7, containing 80% (v/v) 
formamidc. After 5 min at 85”C, the mixtures were incubated at 45, 
55 or 65”C, or subjected to three 65°C (30 min)/45”C (30 min) cycles 
before incubation at 45°C for 16 h. RNase A (1 pg) and RNase Tl 
(15 pg) were added and the mixtures were further incubated at 30°C 
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Fig. I. (A) The cDNA clones ofCDl8. The cDNA clones 38 and J9 are shown with the restriction sites for XhaI (X). BnnI (B), BarnHI (M), EcoRl 
(R), NcdI (N) and .%/cl1 (A) marked on JX. The shaded bar marks the position of the coding region. Also indicated are the positions of the sense 
(AI9: 5’-CCAGGGCAGACTGGTAGCAAAGCC-3’, K IX: S’-GCTTCACGGACATAGTGAC-3’. Fog: 5’.GCTACAACGGCCAGGTCTG-3’) 
and antiscnse (Al 7: 5’-CTGGTCGCAGWAAAGC-3’. A 16: S’GCACGGTCTTGTCCACG-3’) CDIS-specific oligonucleotides. (B) The restric- 
tion map ofthc CD18 gene and exon locations. The restriction sites for &/II (G), f?oRI (R), IlincII (C), X/WI (X), &VII (K), &r,>tHI (M), W;jtdIII 
(H) and .YWI (S) are marked and they arc complete within the region shown. XhnI, Btr,nHI and /?oRI sites are found in the transcribed regions 
in exons I, 4 and 7 respcctivcly. The &l/l cloning sites of the /z clones are marked ‘S’. 
for I h. SDS and proteinase K were added to terminate the RNase 
digestion. After phenol extraction, the undigcstcd double-strand RNA 
was precipitated and analysed by urea-PAGE and autoradiography. 
Two oligonucleotides. KO5 (GGTCGACTCTAGAGGATCC) and 
K06 (K05 with 17 Ts at the 3’ end), were synthesised for RACE-PCR 
]17]. For 5’ end analysis. tirst-strand cDNA was synthesised from 
poly(A) selected RNA from PMA-stimulated U937 ceils using 
reagents from the cDNA Synthesis System Plus (Amersham). Poly(A) 
was added to the single-strand cDNA with terminal deoxynucleotide 
transferase (Bethesda Research Laboratories), The 5’ tailed cDNA 
was used as template for PCR (30 cycles) using K05 (0.25 PM), K06 
(0.1 MM) and the CDlg-specilic oligonucleotidc Al6 (0.25pM) with 
an anIlCaling temperature of 50°C. The pro&lct was further amplified 
twice, 20 cycles each. using KOS (0.25 PM) and the oligonuclcotidc 
Al7 (0.25 @I). with a hi&r annealing temperature of 55”~. A 
similar strategy was used for 3’ end analysis except that doublc- 
stranded cDNA was used as the first-round template making use of 
the naturally occurring poly(A) tail at the 3’ end. 
Lambda-DNA was prepared using QIAGEN-pack 100 (supplied by 
Hybaid Ltd., UK) according to the manufacturer’s instructions. Plas- 
mid cloning was performed with pBluescript KS (Stratagcnc) 
linearised with different enzymes (indicated in brackets) in the poly- 
linker region. Restriction and other nucleic acid modification enzymes 
were purchased from Amcrsham. Boehringer-Mannhcim, Bethesda 
Research Laboratories, New England Biolabs or Pharmacia. Sequenc- 
ing reactions were performed either with the double-stranded plasmid 
clones using the “Sequencing kit (Pharmacia) or with single-strand 
DNA made by transfecting pBluescript clones in E. coli (strain TG-I) 
with the helper phage MIBIK07. using Scquenase version 2.0 or TA- 
Quence DNA sequencing kits (US Biochemical Co.). The M I3 and T3 
primers, as well as CDlg-specific oligonucleotides, ,werc used as 
primers for sequencing. 
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3. RESULTS 
Several cDN.4 clones. including J9 and J 19. of CD I8 
have been previously reported [l9]. Subsequently, a 
clone (58) containing 10 I bases 5’ lo the initiating ATG 
codon was obtained. The six BrtttI fragments of clone 
J9. BNI to BN6. were individually subcloned into the 
vector pATX (Poll). The cDNA clones and their sub- 
cloned fragments are shown in Fig. IA. 
3.2. Genomic clotws of’ rite C’DIK gctw 
/1EMBL3 genomic libraries containing partially 
digested MhoI fragments. generously provided by Dr. 
D.R. Bentley, wcrc screened with the JXXM and J9 
cDNA pro&. A number of CD18 clones were 
obtained. Southern blot analysis using the probes 
JXXM, and BN I 6 established that 3 ofthe clones. AJX. 
LQS and ;1C6, gave maximal covcragc of the gene (Fig. 
I B). Extensive screening of other genomic libraries, in 
/1 or cosmids, failed to yield clones that covered the gap 
between 1QS and LC6. 
The gap was found. by Southern blot analysis of 
genomic DNA, to lie within a 29 kb &III fragment. 
!$$I1 digests of whole genomic DNA was size-frac- 
tionated on a sucrose density gradient. Fractions con- 
taining the highest specific abundance of the 29 kb frag- 
ment were further digested with BarnHI. A library was 
made in pBluescript (BnmHI). Of approximately 8000 
colonies, 3 were positive with the BN2 probe and an- 
other was positive with both BN2 and BN4 probes. One 
of the BN2-positive clones (pMM3) and the BN2/BN4- 
positive clone (pMM4) (Fig. 1 B) were analysed further. 
Preliminary restriction maps of the CD 18 gene were 
established by Southern blot analysis of genomic DNA. 
The A clones were digested with ,%/I and &/II and 
fragments of 5-7 kb were cloned into pBluescript (&IT; 
BantHI; or StiIIIBrlt71HI). Five clones, pJ2, pJ3, pQ8, 
pQ9 and pC64 were obtained. A restriction map for the 
enzymes &/II, EroRI, ZZincII, Xbul, KpnI, BumHI, 
Hind111 and .Sum (Fig. 1B) was generated from analysis 
ofthe 5 plasmid subclones as well as the plasmid clones 
pMM3 and pMM4. Attempts to clone the 2 kb BgllI 
fragment of AQS in pBIuescript were unsuccessful. 
The overlap between pQ9 and pMM3 was established 
by sequencing. Oligonucleotides in exons on either side 
of the junctions between pMM3 and pMM4 and be- 
tween pMM4 and pC64 were made and DNA frag- 
ments were amplified from the genomic DNA template 
by PCR. These fragments were cloned and the se- 
quences obtained established the continuity of the 
clones pMM3, pMM4 and pC64 in the CD 18 gene. 
3.4. E.wtdintron hounchies 
Exonlintron boundaries were established by sequenc- 
ing using one of the following 2 approaches: (1) Oligo- 
nucleotides based on the CD18 cDNA sequence were 
used as primers to sequence various genomic plasmid 
clones directly. (2) The genomic clones were digested 
with either AluI, AvaII, HinfI or NcoI, end-filled, and 
cloned into pBluescript (H&II). Clones containing ex- 
onic fragments were identified by screening, and se- 
quenced. Sixteen exons were found. The exon/intron 
boundaries, including the phase and size of the introns, 
arc shown in Fig. 2. All were found to conform to the 
GTiAG splicing consensus [20]. 
3.5. Iti tron .rixs md c.wn positions 
The size of the introns and the position of the exons 
with rcspcct to the restriction map were established by 
one of 4 methods: (I) Restriction mapping (RM); (2) 
PCR between flanking cxons; (3) partial sequencing 
(pSEQ) where sequences to the nearest restriction en- 
zyme site were determined; and (4) sequencing (SEQ) of 
the entire intron (Fig. 2). The locations of the exons are 
shown in Fig. 1B. 
3.6. 7’lle 5’ cnrl 
J8 is the longest cDNA clone obtained and it includes 
I01 bp of 5’ untranslated sequence. The 5’ 98 bp were 
found in a single stretch in pJ2. Making use of an X&I 
site in this stretch, a hybrid genomic/cDNA clone, pR5’ 
G, containing an A vaII/XbaI genomic fragment and an 
X/WBrm~HI cDNA fragment (J8XM) was constructed 
in the pBIuescript SK+ vector (Fig. 3A). A radiolabelled 
RNA probe was synthesised using T3 RNA polymerase 
and hybridised to total RNA from PMA-stimulated 
U937 cells under various conditions. After digestion of 
unprotected regions with RNase A and RNase Tl, the 
protected regions of the probe were analysed by urea- 
PAGE. Five major bands of 222,228,252,261 and 280 
bases were found when the probe was hybridised to 
U937 RNA but not when hybridised with tRNA (Fig. 
3B). These results suggested that there are multiple in- 
itiation sites of transcription and the major ones lie 
222-280 bases 5’ to the BumHI site in the cDNA, corre- 
sponding to 49-127 bases for the first exon. 
The rapid amplification of cDNA ends (RACE) pro- 
tocol was used to determine the sequence of the 5’ 
cDNA ends. The first round PCR products, using K05, 
K06 and A 16 primers, were further amplified twice for 
20 cycles each with AI7 and K05. The resultant 
products, which appeared as a smear of heterogeneous 
products on agarose gels, were digested with BumHI 
and cloned into pBluescript (BumHI). Eight CDl%spe- 
cific clones were obtained by screening with oligonu- 
cleotide Al9 and analysed by sequencing. They contain 
80-127 nucleotides 5’ from the putative Exon l/Exon 2 
junction, all with sequences identical to the genomic 
sequence. Similar results were obtained using other 
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T:xon 1 A(:CG'I'GG'I'GCAA(:CCAC(;AC'~TC(:TCCAA~GAC~;AGCTGA(;~G(;A~~AG(;AAG'~~;'~(;A(;(~~(:'~"l"!'~(;~;A:'~~~:!~~.~,~:~:'~'~:~: 
(49-12-i bp) 
EXOrl 7 
(61 hp) 
Exon 3 C Q K I, 
(89 bp) 1'CCCACAACCTl;(~tadgi.qccl.... 
Exon 4 
(181 bp) 
Y 1. I< I’ 
TACCTCCGACCAi;q:aggcl '.qy. . 
EXOrl 5 
(1'11 bp) 
s G R I 
TCCGGCCGCATTCqtyayyccca.. 
Exon 6 
(242 bp) 
A A C P 
GCCCCCTGcCCCqtgaygccgc... 
Exon 7 
(156 bp) 
S N E I: 
AGCMCGAA'~TCq~aaqtccc:c........(l.2 kb RM/PCR/pSEQ)... 
Exon 8 
(96 bp) 
K 'T Y 1: InLron 8/9: phase 0 
AAGACCTACGA~qcgaytyctq............(3.9 kb, RM) . . . . . . . 
EXOrl 9 
(90 bp) 
NAY N intron 9/10: phase 0 
AATGCTTACAATq~qayLcLcc..........(1.45 kb, PcK/pSEQ)... 
EXOrl 10 
(142 bp) 
I NV P Intron 10/11: phase 0 
ATcAATGTcCCG(jigaqccLqg...........(1.35 kb, PCR) . . . . . . 
Exon I1 
(188 bp) 
G 1 C 1~ Intran 11/12: phase 2 
GGCATCTGCAGqtga~gcg~~............(1.75 kb, PCR)...... 
Exon 12 
(245 bp) 
C G G P Intron 12/13: phase 1 
TGCGGCGGCCcGGqtqaqcccgt........ (-500 bp, PCK/pSEQ)... 
Exon 13 
(220 bp) 
G K Y I In~ron 13/14: phase 2 
GGCAAGTACAT~L~d~~t~ca~.............(-400 bp, PCR)..... 
Exon 14 
(203 bp) 
D E S R Intron 14/15: phase 1 
GATGAGRGCCGAGgtgaqgccgc............(1.6 kb, PCR)..... 
rxon 15 
(166 bp) 
Q W N N Intron 15/16: phase 0 
CAGTGGAACAATqtaagLygcc.............(303 bp, SEQ)..... 
Exon 16 
(-475 bp) 
FKSATTTVMNPKFAES* 
TTCAAGAGCGCCACCACGACGGTCATGAACCCCAAGT'~TGCTGAGAGTTAGGAGCACTTGGTGAAGACAAGGCCG'~CA(;G 
1nLron 3/4: phase 0 
(3.2 kb, RM).... 
Intron 4/5: phase 1 
. . (3.4 kb, RM/pSEQ).. 
InLroII 5/6: phase 1 
.(1.65 kb, PCR/pSEa). 
lnt.ron 6/7: phase 0 
-950 bp, RM/PCR/pSRQ) 
Tntron 7/E: phase 0 
Ci F C S 
.tqccctgcaqCCTTCGCGTCC 
. . 
I) Y P s 
ctcLcrccayC,AC'l'ACCCA~'CG 
K I. 'T E 
. tgcccaacaqRAACTCACCGAG 
K L s s 
. . . ctgcccgcagAAACTCTCC'~CC 
I T F Q 
, . . . tqccctgcagATCACCTTCCAG 
C D 'r G 
ctgLccccagGTGTGACACTGGC 
C R G L 
. . CgtcttccaqGGAGGGGGCTc 
s c A E 
CtCCCCgCaqCTCCTGCGCCGAG 
i: C V A 
. . . tcttccctagAG?GTGTGGCA 
D N P L 
. . ttcccdccagGATAATCCCCTT 
CAGTTATTTTCCGCCCTCAMATGACAGCCATGGCCGGCCGGGTGCTTCTGGGGGCTCGTCGGGGGGACACCTCCACTCT 
TTATATTGTTAATCAATCACGTGT~?'AGAAAAAAAA~AAAACTTCAA~ACAGGCTCTCCATGGAAACTGGGCAC~'~~~~G'~C 
I II II 
F: 1 1 I 
u: 2 1 16 
n A 
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CD18-specific oligonucleotides as primers at the am- 
plification stages. Since these clones were screened with 
the oligonuclcotide Al9. they are biased for clones ex- 
tended 5’ to A19. The initiation sites, as determined by 
the 2 methods, are shown in Fig. 2 (Exon 1). 
3.1. Tl7e 3’ etzcl (4 
In the course of our studies on the cDNA clones of 
CD18, 2 types of clone wcrc found; those with an Ncol 
site at the 3’ end, such as J9 and 58, and those without, 
such as J19. Sequencing revealed that the 6 bases im- 
mediately preceding the poly(A) tail are CCATGG, 
which account for the presence of the NcoI site. On the 
other hand, the last 5 bases are not found in J19. This 
phenomenon was investigated further using RACE at 
the 3’end. cDNA prepared from poly(A) selected RNA 
of PMA-stimulated IJ937 cells (U) or an EBV-trans- 
formed cell line (F) were used as templates. PCR was 
first performed with the oligonucleotides K18 and a 
mixture of KO5 and K06 for 30 cycles. The product was 
further amplified for 20 cycles using the oligonu- 
cleotides F08 and K05. The fragment between the Sac11 
site within the cDNA sequence and the BamHI site 
within K05 was cloned into pBluescript (SucIIIBumHI). 
Nine clones from F and 10 from U were analysed by 
sequencing. There are at lcast 5 different poly(A) addi- 
tion sites but 7 out of 10 clones from F and 6 of 9 clones 
from U have the same site as 58 and J9 (Fig. 2, Exon 
16). 
4. DISCUSSION 
We have obtained genomic clones which cover the 
transcribed region of the CD18 gene. The gene spans 
approximately 40 kb and is organised into 16 exons. All 
the exonic segments of the genomic clones have been 
sequenced to establish formally their continuity. Two 
exoniintron boundaries of the CD18 gene have been 
previously reported. In the study of a patient with leu- 
kocyte adhesion deficiency, the defect was caused by a 
mutation in a splice site leading to the deletion of Exon 
9 in the mRNA [15]. In addition, an aberrant cDNA 
clone of the mouse CD1 8 led Zeger et al. [21] to propose 
an exomintron boundary which is equivalent to the 5’ 
boundary of Exon 13. 
Fig. 3. The initiation sites of transcription of the CD18 gene. (A) The 
genomic-cDNA hybrid clone (pR5’G) in pBluescript (SK+) construct- 
ed for the purpose of making RNA probes. The dark-shaded region 
is from the genomic lone pJ2 whereas the light-shaded region is from 
the cDNA clone J8. (B). RNase protection studies. The RNA probe 
made from pR5’G was hybridised to total RNA from U937 (tracks 
ad) and tRNA (tracks e-h) followed by digestion with RNase A and 
RNase Tl. The hybridisation was at 45°C (tracks a and e), 55OC 
(tracks b and f) and 65°C (tracks c and g). Samples in tracks d and 
h were subjected to three 65W45”C cycles before incubation at 45°C 
for 16 h. The size markers (in nucleotides, nt) were from a sequencing 
We have used both hybridisation/protection and 
primer extension type experiments to study the 5’ end 
of the CD18 gene. Five major initiation sites were found 
with RNA protection using an RNA probe. Primer ex- 
tension experiments confirmed the existence of multiple 
transcription initiation sites (data not shown), which 
were found to be more scattered and in general indica- 
tive of a more 3’ start. This may be caused by the high 
G+C content of the region (>60%) affecting the ef- 
ficiency of the reverse transcriptase. The RACE-PCR 
cloning experiments, on the other hand, were biased 
towards longer clones since they were screened with the 
oligonucleotide A19. In addition, the RACE-PCR 
clones have sequences 5’ extended along the genomic 
sequence. Taking these results together, we may con- 
clude that (i) there are multiple initiation sites of tran- 
100- 
December 199 1 
abed elgh 
reaction run on the same gel (not shown). 
Fig, 2. The exoniintron boundaries of the CD18 gene. The phase of the introns, their size, and the method used for size determination are indicated. 
Genomic sequence running into Exon I is shown. Initiation sites of transcription determined by RNase protection (+) and those by RACE-PCR 
(*) are marked. The first base of the cDNA clone 58 is indicated (0). The sequence of Exon 16 is shown and the first A of the poly(A) tails are 
marked by (I). Indicated below the markers are the number of clones found with RNA from F (an EBV-transformed cell line) and U (the cell line 
U937). The polyadenylation sites of the cDNA clones J19 (“) and J8 and J9 (n) are also indicated. 
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Fig. 4. The exons of the 82 intcgrin subunit (Cl11 8) aligned with those of the /jl [37], p3 [37,3X] and 87 intcgrin subunits [36]. The coding regions 
are enclosed between the vertical dotted lincb in Hxons 2 and 16. The phases of the introns are shown in square boxes between exons. The phases 
of the introns of p3. where diffcrcnt from those ofg2. arc also shown. Both PI [3Y] and 83 [40] have 2 ahcrnative transcripts resulting from the 
non-splicing of the intron equivalent to that hctwccn El 5 and T:16 in 82. The boundaries ofp7 wcrc determined from incompletely processed and 
alternatively spliced cDNA clones; hence the cxons in bctwcen were not defined formally [36]. Also marked are the position ofthe 56 cysteine residues 
in the extraccllular domains of the /32 subunit. 
scription, and (ii) the region studied is the first exon. We presence of variant products, suggesting that alternative 
have found no TATA box motif immediately upstream splicing of thep2 message does not occur at a significant 
of the initiation site cluster which may explain the ob- level, at least not in PMA-stimulated U937 or EBV- 
served heterogeneity. transformed cells. 
The polyadenylation site at the 3’ end is also hctcr- 
ogeneous. There is only one AATAAA signal, but 
poly(A) addition is found at several sites around 20 
nucleotides from the AATAAA signal, with one major 
site accounting for about 70% of the clones studied. It 
is generally accepted that a GT-rich region 20.-30 nu- 
cleotides 3’ to the site is required for efficient polya- 
denylation [22-241. The absence of a pronounced GT- 
rich element in this region may account for the lack of 
a single polyadenylation site of the CD 18 message (Fig. 
2). 
The CD18 antigen is the p2 subunit of the integrin 
superfamily. To date, the primary structures of at least 
6 other p subunits have been determined [19,25-361. 
They share similar sequence features, with highly con- 
served cysteine residues in their extracellular domains. 
Fourteen exon/intron boundaries of the/J3 intcgrin sub- 
unit (gpIIIa) have been determined [37,38], 3 of which 
are different from those of the p2 gene (Fig. 4). The 
locations and phases of the introns between Exons 5 
and 6 ofp2, and their counterparts in 83 are different. 
The boundary between Exon 11 and Exon 12 is not 
found in 83, and there are 2 exons in ,83 corresponding 
to Exon 14 of/32. Eight exon boundaries of/31 [37] and 
5 ofp7 [36] have also been reported. They are identical 
to those of/?2 but not necessarily to those ofa3, suggest- 
ing that pl, /?2 and 87 are more closely related, in evolu- 
tionary terms, to each other than any is to 83. 
Primary structure analysis of the /32 and other p in- 
tegrin subunits invariably shows repeating elements in 
the cysteine-rich region. Although it is generally agreed 
that each repeating element contains 8 cysteine residues, 
the units themselves have not been defined since it is not 
clear where the boundaries lie. It is not uncommon to 
find structural motifs in proteins encoded by separate, 
or by a discrete number of exons [41]. However, Exons 
11 to 14, which encode the cystcine-rich region, contain 
7, 13, I6 and 6 cysteine residues, respectively, and there- 
fore provide no information on the putative repeating 
elements. Thus the definition of these motifs must await 
further work at the protein level. 
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